Related references
Note: Only part of the references are listed.Two further cases of polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome, caused by a truncating variant in STRADA
Hessa S. Alsaif et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2021)
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
Katarzyna Kotulska et al.
ANNALS OF NEUROLOGY (2021)
Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association
Christina Sidira et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2021)
Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies
Pierre-Olivier Grenier et al.
JAMA DERMATOLOGY (2021)
Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex A Placebo-Controlled Randomized Clinical Trial
Elizabeth A. Thiele et al.
JAMA NEUROLOGY (2021)
Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin
Pike-See Cheah et al.
SCIENCE ADVANCES (2021)
Homozygous missense STRADA mutation in a patient with polyhydramnios, megalencephaly and symptomatic epilepsy syndrome
Mio Aerden et al.
CLINICAL DYSMORPHOLOGY (2021)
Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders The Power of 1
Annelieke R. Mueller et al.
NEUROLOGY (2021)
Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome
Karina Forde et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients
Seyeon Kim et al.
ANNALS OF NEUROLOGY (2021)
TuberOus SClerosis registry to increAse disease awareness (TOSCA) Post-Authorisation Safety Study of Everolimus in Patients With Tuberous Sclerosis Complex
J. Chris Kingswood et al.
FRONTIERS IN NEUROLOGY (2021)
PTEN somatic mutations contribute to spectrum or cerebral overgrowth
Daniel C. Koboldt et al.
BRAIN (2021)
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' Perspectives
Laurent M. Willems et al.
CNS DRUGS (2021)
Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain
Zimeng Ye et al.
BRAIN COMMUNICATIONS (2021)
Epilepsy genetics: clinical impacts and biological insights
Colin A. Ellis et al.
LANCET NEUROLOGY (2020)
Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China
Shiyong Liu et al.
BRAIN (2020)
Mechanisms of resistance to mTOR inhibitors
Luigi Formisano et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Diagnostic exome sequencing in non-acquired focal epilepsies highlights a major role of GATOR1 complex genes
Martin Krenn et al.
JOURNAL OF MEDICAL GENETICS (2020)
Discovery of a Brain-Penetrant ATP-Competitive Inhibitor of the Mechanistic Target of Rapamycin (mTOR) for CNS Disorders
Simone Bonazzi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy
Ruby E. Dawson et al.
NEUROBIOLOGY OF DISEASE (2020)
Cannabidiol Elevates Mechanistic Target of Rapamycin Inhibitor Levels in Patients With Tuberous Sclerosis Complex
Daniel Ebrahimi-Fakhari et al.
PEDIATRIC NEUROLOGY (2020)
A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability
Katherine A. Benson et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2020)
TSC2pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study
Barbara Ogorek et al.
GENETICS IN MEDICINE (2020)
Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1
Lindsay K. Klofas et al.
HUMAN MOLECULAR GENETICS (2020)
Definitions and classification of malformations of cortical development: practical guidelines
Mariasavina Severino et al.
BRAIN (2020)
Polymicrogyria is Associated With Pathogenic Variants inPTEN
Diane D. Shao et al.
ANNALS OF NEUROLOGY (2020)
Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons
Andrew M. Tidball et al.
BRAIN (2020)
Genetic characterization identifies bottom-of-sulcus dysplasia as an mTORopathy
Wei Shern Lee et al.
NEUROLOGY (2020)
The landscape of epilepsy-related GATOR1 variants
Sara Baldassari et al.
GENETICS IN MEDICINE (2019)
Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex
Catherine L. Salussolia et al.
Annual Review of Genomics and Human Genetics (2019)
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study
Afshin Saffari et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II
Shanshan Zhao et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex
Iris E. Overwater et al.
NEUROLOGY (2019)
Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA
Wei Shern Lee et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Precise detection of low-level somatic mutation in resected epilepsy brain tissue
Nam Suk Sim et al.
ACTA NEUROPATHOLOGICA (2019)
Dissecting the genetic basis of focal cortical dysplasia: a large cohort study
Sara Baldassari et al.
ACTA NEUROPATHOLOGICA (2019)
Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
Yen-Chen Anne Feng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Tackling Epilepsy With High-definition Precision Medicine: A Review
Hugh Kearney et al.
JAMA NEUROLOGY (2019)
A Randomized, Controlled Trial of the Analytic and Diagnostic Performance of Singleton and Trio, Rapid Genome and Exome Sequencing in III Infants
Stephen F. Kingsmore et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Scalp EEG spikes predict impending epilepsy in TSC infants: A longitudinal observational study
Joyce Y. Wu et al.
EPILEPSIA (2019)
GATORopathies: The role of amino acid regulatory gene mutations in epilepsy and cortical malformations
Philip H. Iffland et al.
EPILEPSIA (2019)
mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case Report
Qi Xu et al.
JOURNAL OF CHILD NEUROLOGY (2019)
Clinical Letter: A case report of targeted therapy with sirolimus for NPRL3 epilepsy
Marissa Vawter-Lee et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies
J. Walker Blackston et al.
HEALTHCARE (2019)
mTOR mutations in Smith-Kingsmore syndrome: Four additional patients and a review
G. Gordo et al.
CLINICAL GENETICS (2018)
Dramatic relapse of seizures after everolimus withdrawal
Alessia Mingarelli et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia-associated epilepsy
Theo Ribierre et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility
Christopher J. Yuskaitis et al.
NEUROBIOLOGY OF DISEASE (2018)
Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy
E. Marsan et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Oral stomatitis and mTOR inhibitors: A review of current evidence in 20,915 patients
L. Lo Muzio et al.
ORAL DISEASES (2018)
Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization
Lauge Farnaes et al.
NPJ GENOMIC MEDICINE (2018)
Somatic Depdc5 deletion recapitulates electroclinical features of human focal cortical dysplasia type IIA
Shuntong Hu et al.
ANNALS OF NEUROLOGY (2018)
Targeted therapy in patients with PIK3CA-related overgrowth syndrome
Quitterie Venot et al.
NATURE (2018)
Novel Homozygous Deletion in STRADA Gene Associated With Polyhydramnios, Megalencephaly, and Epilepsy in 2 Siblings: Implications for Diagnosis and Treatment
Katherine Nelson et al.
JOURNAL OF CHILD NEUROLOGY (2018)
Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial
David N. Franz et al.
NEUROLOGY-CLINICAL PRACTICE (2018)
Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review
Remi Stevelink et al.
EPILEPTIC DISORDERS (2018)
Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
Andrew S. Allen et al.
LANCET NEUROLOGY (2017)
KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1
Rachel L. Wolfson et al.
NATURE (2017)
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
I. Blumcke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
De novo mutation in DEPDC5 associated with unilateral pachygyria and intractable epilepsy
Zhidong Cen et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
The genomic landscape of tuberous sclerosis complex
Katie R. Martin et al.
NATURE COMMUNICATIONS (2017)
Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias
Alissa M. D'Gama et al.
CELL REPORTS (2017)
Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders
Darcy A. Krueger et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Autistic Siblings with Novel Mutations in Two Different Genes: Insight for Genetic Workups of Autistic Siblings and Connection to Mitochondrial Dysfunction
Barrett J. Burger et al.
FRONTIERS IN PEDIATRICS (2017)
Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling
James Hughes et al.
SCIENTIFIC REPORTS (2017)
Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia
Jae Seok Lim et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Familial Cortical Dysplasia Caused by Mutation in the Mammalian Target of Rapamycin Regulator NPRL3
Joe C. Sim et al.
ANNALS OF NEUROLOGY (2016)
Mutations in the Mammalian Target of Rapamycin Pathway Regulators NPRL2 and NPRL3 Cause Focal Epilepsy
Michael G. Ricos et al.
ANNALS OF NEUROLOGY (2016)
Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE)
Weimin Bi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2016)
Exome-based analysis of cardiac arrhythmia, respiratory control, and epilepsy genes in sudden unexpected death in epilepsy
Richard D. Bagnall et al.
ANNALS OF NEUROLOGY (2016)
Nocturnal frontal lobe epilepsy caused by a mutation in the GATOR1 complex gene NPRL3
Georg-Christoph Korenke et al.
EPILEPSIA (2016)
Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia
Sarah Weckhuysen et al.
EPILEPSIA (2016)
Safety of mTOR inhibitors in adult solid organ transplantation
Pedro Ventura-Aguiar et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy
Katherine L. Helbig et al.
GENETICS IN MEDICINE (2016)
GATOR1 complex: the common genetic actor in focal epilepsies
Sara Baldassari et al.
JOURNAL OF MEDICAL GENETICS (2016)
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Jacqueline A. French et al.
LANCET (2016)
The mTOR signalling cascade: paving new roads to cure neurological disease
Peter B. Crino
NATURE REVIEWS NEUROLOGY (2016)
Depdc5 knockout rat: A novel model of mTORopathy
Elise Marsan et al.
NEUROBIOLOGY OF DISEASE (2016)
Therapeutic Drug Monitoring of Everolimus: A Consensus Report
Maria Shipkova et al.
THERAPEUTIC DRUG MONITORING (2016)
The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial
Elizabeth Randell et al.
TRIALS (2016)
Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement
Lawrence S. Hsieh et al.
NATURE COMMUNICATIONS (2016)
Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism
Ghayda M. Mirzaa et al.
JAMA NEUROLOGY (2016)
Tuberous sclerosis complex
Elizabeth P. Henske et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study
David N. Franz et al.
PLOS ONE (2016)
Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy
Rikke S. Moller et al.
NEUROLOGY-GENETICS (2016)
PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution
Ghayda Mirzaa et al.
JCI INSIGHT (2016)
Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants
Charu Venkatesan et al.
EPILEPTIC DISORDERS (2016)
Novel Homozygous Mutation in KPTN Gene Causing a Familial Intellectual Disability-Macrocephaly Syndrome
Sander Pajusalu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2015)
Familial Focal Epilepsy with Focal Cortical Dysplasia Due to DEPDC5 Mutations
Stephanie Baulac et al.
ANNALS OF NEUROLOGY (2015)
Mammalian Target of Rapamycin Pathway Mutations Cause Hemimegalencephaly and Focal Cortical Dysplasia
Alissa M. D'Gama et al.
ANNALS OF NEUROLOGY (2015)
PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia
Laura A. Jansen et al.
BRAIN (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex
Nicholas Rensing et al.
EPILEPSIA (2015)
mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia
Lena H. Nguyen et al.
EPILEPSIA (2015)
Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing study
Ghayda M. Mirzaa et al.
LANCET NEUROLOGY (2015)
Neurological and neuropsychiatric aspects of tuberous sclerosis complex
Paolo Curatolo et al.
LANCET NEUROLOGY (2015)
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy
Jae Seok Lim et al.
NATURE MEDICINE (2015)
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex
Jeffrey P. MacKeigan et al.
NEURO-ONCOLOGY (2015)
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist
Petrus J. de Vries et al.
PEDIATRIC NEUROLOGY (2015)
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
Magdalena E. Tyburczy et al.
PLOS GENETICS (2015)
Preliminary Functional Assessment and Classification of DEPDC5 Variants Associated with Focal Epilepsy
Melissa van Kranenburg et al.
HUMAN MUTATION (2015)
Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5
Thomas Scerri et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Overgrowth Syndromes
Andrew C. Edmondson et al.
JOURNAL OF PEDIATRIC GENETICS (2015)
Epileptic spasms are a feature of DEPDC5 mTORopathy
Gemma L. Carvill et al.
NEUROLOGY-GENETICS (2015)
Epilepsy with auditory features A heterogeneous clinico-molecular disease
Tommaso Pippucci et al.
NEUROLOGY-GENETICS (2015)
Mutations in KPTN Cause Macrocephaly, Neurodevelopmental Delay, and Seizures
Emma L. Baple et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
Mutations in Mammalian Target of Rapamycin Regulator DEPDC5 Cause Focal Epilepsy with Brain Malformations
Ingrid E. Scheffer et al.
ANNALS OF NEUROLOGY (2014)
DEPDC5 Mutations in Genetic Focal Epilepsies of Childhood
Dennis Lal et al.
ANNALS OF NEUROLOGY (2014)
Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes
Bradley J. Atkinson et al.
BJU INTERNATIONAL (2014)
AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH
K. Nakamura et al.
CLINICAL GENETICS (2014)
A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population
C. Martin et al.
CLINICAL GENETICS (2014)
Developmental brain abnormalities in tuberous sclerosis complex: A comparative tissue analysis of cortical tubers and perituberal cortex
Veronique Ruppe et al.
EPILEPSIA (2014)
TBC1D7 Mutations are Associated with Intellectual Disability, Macrocrania, Patellar Dislocation, and Celiac Disease
Ali Abdullah Alfaiz et al.
HUMAN MUTATION (2014)
Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia
Carlos Cepeda et al.
NEUROBIOLOGY OF DISEASE (2014)
DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy
Fabienne Picard et al.
NEUROLOGY (2014)
Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation
Candi L. LaSarge et al.
Frontiers in Molecular Neuroscience (2014)
Biallelic SZT2 Mutations Cause Infantile Encephalopathy with Epilepsy and Dysmorphic Corpus Callosum
Lina Basel-Vanagaite et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
TORC1-Dependent Epilepsy Caused by Acute Biallelic Tsc1 Deletion in Adult Mice
Elisabeth Abs et al.
ANNALS OF NEUROLOGY (2013)
Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly
Jose-Mario Capo-Chichi et al.
JOURNAL OF MEDICAL GENETICS (2013)
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
David Neal Franz et al.
LANCET (2013)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler et al.
LANCET (2013)
Mutations of DEPDC5 cause autosomal dominant focal epilepsies
Saeko Ishida et al.
NATURE GENETICS (2013)
Mutations in DEPDC5 cause familial focal epilepsy with variable foci
Leanne M. Dibbens et al.
NATURE GENETICS (2013)
Mystery Case: Cowden syndrome presenting with partial epilepsy related to focal cortical dysplasia
Nicholas D. Child et al.
NEUROLOGY (2013)
Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder
Whitney E. Parker et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: Two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis
Ghayda M. Mirzaa et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2012)
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma
L. Albiges et al.
ANNALS OF ONCOLOGY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Genotype and cognitive phenotype of patients with tuberous sclerosis complex
Agnies M. van Eeghen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex
Sharon W. Way et al.
HUMAN MOLECULAR GENETICS (2012)
Nprl3 is required for normal development of the cardiovascular system
Monika S. Kowalczyk et al.
MAMMALIAN GENOME (2012)
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
Jean-Baptiste Riviere et al.
NATURE GENETICS (2012)
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
Jeong Ho Lee et al.
NATURE GENETICS (2012)
Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex
Ling-Hui Zeng et al.
HUMAN MOLECULAR GENETICS (2011)
Functional Assessment of Variants in the TSC1 and TSC2 Genes Identified in Individuals with Tuberous Sclerosis Complex
Marianne Hoogeveen-Westerveld et al.
HUMAN MUTATION (2011)
Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex
A. L. Numis et al.
NEUROLOGY (2011)
A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome
Marjorie J. Lindhurst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The natural history of epilepsy in tuberous sclerosis complex
Catherine J. Chu-Shore et al.
EPILEPSIA (2010)
STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
Ksenia A. Orlova et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Biallelic TSC gene inactivation in tuberous sclerosis complex
Peter B. Crino et al.
NEUROLOGY (2010)
Progressive multifocal cystlike cortical tubers in tuberous sclerosis complex: Clinical and neuropathologic findings
Catherine J. Chu-Shore et al.
EPILEPSIA (2009)
Sirolimus and Everolimus Induced Pneumonitis in Adult Renal Allograft Recipients: Experience in a Center
A. Rodriguez-Moreno et al.
TRANSPLANTATION PROCEEDINGS (2009)
Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers
Delia M. Talos et al.
ANNALS OF NEUROLOGY (2008)
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
Ling-Hui Zeng et al.
ANNALS OF NEUROLOGY (2008)
Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies
Monica M. Mita et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome- a single-centre experience and review of the literature
Stefan M. Weiner et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Differential Pi3K-pathway activation in cortical tubers and focal cortical dysplasias with balloon cells
Volker Schick et al.
BRAIN PATHOLOGY (2007)
Tuberous sclerosis complex and epilepsy: Recent developments and future challenges
Gregory L. Holmes et al.
EPILEPSIA (2007)
Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia
M. Cecilia Ljungberg et al.
ANNALS OF NEUROLOGY (2006)
Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis
Carlos Cepeda et al.
EPILEPSY & BEHAVIOR (2006)
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
SF Tavazoie et al.
NATURE NEUROSCIENCE (2005)
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations
MG Butler et al.
JOURNAL OF MEDICAL GENETICS (2005)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
mTOR cascade activation distinguishes tubers from focal cortical dysplasia
M Baybis et al.
ANNALS OF NEUROLOGY (2004)
Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia
C Cepeda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex
C Joinson et al.
PSYCHOLOGICAL MEDICINE (2003)
Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain
N Serkova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs
SL Dabora et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
